• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗体在基孔肯雅病毒感染控制中的重要作用。

An essential role of antibodies in the control of Chikungunya virus infection.

机构信息

Singapore Immunology Network, Agency for Science, Technology and Research, Biopolis, Singapore 138648.

出版信息

J Immunol. 2013 Jun 15;190(12):6295-302. doi: 10.4049/jimmunol.1300304. Epub 2013 May 13.

DOI:10.4049/jimmunol.1300304
PMID:23670192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3677171/
Abstract

In recent years, Chikungunya virus (CHIKV) was responsible for epidemic outbreaks in intertropical regions. Although acquired immunity has been shown to be crucial during CHIKV infection in both humans and mice, their exact role in the control of CHIKV infection remains unclear. In this study, wild-type (WT), CD4(-/-), and B cell (μMT) knockout mice were infected with CHIKV. Sera were taken at different days postinfection and measured for anti-CHIKV Ab levels. Isotype and neutralizing capacity of these Abs were assessed in vitro, and specific linear epitopes were mapped. Viremia in CHIKV-infected μMT mice persisted for more than a year, indicating a direct role for B cells in mediating CHIKV clearance. These animals exhibited a more severe disease than WT mice during the acute phase. Characterization of CHIKV-specific Abs revealed that anti-CHIKV Abs were elicited early and targeted epitopes mainly at the C terminus of the virus E2 glycoprotein. Furthermore, CD4(-/-) mice could still control CHIKV infection despite having lower anti-CHIKV Ab levels with reduced neutralizing capacity. Lastly, pre-existing natural Abs in the sera of normal WT mice recognized CHIKV and were able to partially inhibit CHIKV. Taken together, natural and CHIKV infection-induced specific Abs are essential for controlling CHIKV infections.

摘要

近年来,基孔肯雅病毒(CHIKV)在热带地区引发了疫情爆发。尽管在人类和小鼠的 CHIKV 感染中,获得性免疫被证明是至关重要的,但它们在控制 CHIKV 感染中的确切作用仍不清楚。在这项研究中,野生型(WT)、CD4(-/-)和 B 细胞(μMT)敲除小鼠感染了 CHIKV。在不同的感染后天数采集血清,并测量抗 CHIKV Ab 水平。在体外评估这些 Abs 的同种型和中和能力,并绘制特异性线性表位。在 CHIKV 感染的 μMT 小鼠中,病毒血症持续了一年多,表明 B 细胞在介导 CHIKV 清除中具有直接作用。这些动物在急性阶段的疾病比 WT 小鼠更为严重。对 CHIKV 特异性 Abs 的表征表明,抗 CHIKV Abs 被早期诱导,并主要针对病毒 E2 糖蛋白的 C 末端靶向表位。此外,尽管 CD4(-/-)小鼠的抗 CHIKV Ab 水平较低,中和能力降低,但仍能控制 CHIKV 感染。最后,正常 WT 小鼠血清中的天然存在的 Abs 识别 CHIKV,并能部分抑制 CHIKV。总之,天然和 CHIKV 感染诱导的特异性 Abs 对于控制 CHIKV 感染是必不可少的。

相似文献

1
An essential role of antibodies in the control of Chikungunya virus infection.抗体在基孔肯雅病毒感染控制中的重要作用。
J Immunol. 2013 Jun 15;190(12):6295-302. doi: 10.4049/jimmunol.1300304. Epub 2013 May 13.
2
Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein.感染患者对基孔肯雅病毒的早期中和 IgG 应答靶向 E2 糖蛋白上的一个显性线性表位。
EMBO Mol Med. 2012 Apr;4(4):330-43. doi: 10.1002/emmm.201200213. Epub 2012 Mar 5.
3
Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model.解析适应性免疫对 CHIKV/IRES 的保护作用:一种针对基孔肯雅热的新型候选疫苗在 A129 小鼠模型中的作用。
Vaccine. 2013 Jul 18;31(33):3353-60. doi: 10.1016/j.vaccine.2013.05.059. Epub 2013 May 29.
4
Effects of Chikungunya virus immunity on Mayaro virus disease and epidemic potential.基孔肯雅病毒免疫对马亚罗病毒病和流行潜力的影响。
Sci Rep. 2019 Dec 31;9(1):20399. doi: 10.1038/s41598-019-56551-3.
5
A small antigenic determinant of the Chikungunya virus E2 protein is sufficient to induce neutralizing antibodies which are partially protective in mice.基孔肯雅病毒E2蛋白的一个小抗原决定簇足以诱导产生中和抗体,这些抗体在小鼠中具有部分保护作用。
PLoS Negl Trop Dis. 2015 Apr 23;9(4):e0003684. doi: 10.1371/journal.pntd.0003684. eCollection 2015 Apr.
6
Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.抗基孔肯雅病毒单克隆抗体抑制病毒融合和释放。
J Virol. 2020 Sep 15;94(19). doi: 10.1128/JVI.00252-20.
7
A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease.一种针对基孔肯雅病毒 E2 中酸敏感区域的中和单克隆抗体可预防疾病。
PLoS Negl Trop Dis. 2013 Sep 12;7(9):e2423. doi: 10.1371/journal.pntd.0002423. eCollection 2013.
8
Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutants.人源抗体逃逸突变体揭示了基孔肯雅病毒中和抗原和直接细胞间传播。
PLoS Pathog. 2011 Dec;7(12):e1002390. doi: 10.1371/journal.ppat.1002390. Epub 2011 Dec 1.
9
Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence.致病性基孔肯雅病毒逃避B细胞反应以建立持续性感染。
Cell Rep. 2016 Aug 2;16(5):1326-1338. doi: 10.1016/j.celrep.2016.06.076. Epub 2016 Jul 21.
10
Near-germline human monoclonal antibodies neutralize and protect against multiple arthritogenic alphaviruses.接近种系的人源单克隆抗体可中和并预防多种致关节炎的甲病毒。
Proc Natl Acad Sci U S A. 2021 Sep 14;118(37). doi: 10.1073/pnas.2100104118.

引用本文的文献

1
Humoral and cellular immune response to a single dose of a novel bivalent recombinant adenovirus-vector vaccine against West Nile virus and chikungunya virus in mice.小鼠对单剂量新型二价重组腺病毒载体西尼罗河病毒和基孔肯雅病毒疫苗的体液免疫和细胞免疫反应
Virol J. 2025 Jul 25;22(1):256. doi: 10.1186/s12985-025-02878-5.
2
MyD88 signalling in B cells and antibody responses during Oropouche virus-induced neurological disease in mice.小鼠奥罗普切病毒诱导的神经疾病期间B细胞中的MyD88信号传导与抗体反应
EBioMedicine. 2025 Jun 16:105815. doi: 10.1016/j.ebiom.2025.105815.
3
Long-term persistence of serum IgM antibodies against chikungunya virus in patients with chronic arthralgia.慢性关节痛患者血清中抗基孔肯雅病毒IgM抗体的长期持续存在。
Virol J. 2025 Apr 24;22(1):115. doi: 10.1186/s12985-025-02721-x.
4
Deep mutationally scanned CHIKV E3/E2 virus library maps viral amino acid preferences and predicts viral escape mutants of neutralizing CHIKV antibodies.深度突变扫描的基孔肯雅病毒E3/E2病毒文库绘制了病毒氨基酸偏好图谱,并预测了中和基孔肯雅病毒抗体的病毒逃逸突变体。
J Virol. 2025 Apr 15;99(4):e0008125. doi: 10.1128/jvi.00081-25. Epub 2025 Mar 27.
5
Pathogenesis and clinical management of arboviral diseases.虫媒病毒病的发病机制与临床管理
World J Virol. 2025 Mar 25;14(1):100489. doi: 10.5501/wjv.v14.i1.100489.
6
Deep mutationally scanned (DMS) CHIKV E3/E2 virus library maps viral amino acid preferences and predicts viral escape mutants of neutralizing CHIKV antibodies.深度突变扫描(DMS)的基孔肯雅病毒E3/E2病毒文库绘制了病毒氨基酸偏好图谱,并预测了中和基孔肯雅病毒抗体的病毒逃逸突变体。
bioRxiv. 2024 Dec 4:2024.12.04.626854. doi: 10.1101/2024.12.04.626854.
7
Type I interferon signaling in dendritic cells limits direct antigen presentation and CD8 T cell responses against an arthritogenic alphavirus.树突状细胞中的I型干扰素信号传导限制了直接抗原呈递以及针对致关节炎甲病毒的CD8 T细胞反应。
mBio. 2024 Dec 11;15(12):e0293024. doi: 10.1128/mbio.02930-24. Epub 2024 Nov 13.
8
Obesity-Associated Changes in Immune Cell Dynamics During Alphavirus Infection Revealed by Single Cell Transcriptomic Analysis.单细胞转录组分析揭示甲病毒感染期间肥胖相关的免疫细胞动力学变化
bioRxiv. 2024 Oct 13:2024.10.10.617696. doi: 10.1101/2024.10.10.617696.
9
Pathogenicity and virulence of chikungunya virus.基孔肯雅病毒的致病性和毒力。
Virulence. 2024 Dec;15(1):2396484. doi: 10.1080/21505594.2024.2396484. Epub 2024 Sep 1.
10
Cross-Neutralizing Anti-Chikungunya and Anti-Dengue 2 IgG Antibodies from Patients and BALB/c Mice against Dengue and Chikungunya Viruses.抗基孔肯雅热和抗登革热 2 型 IgG 抗体的交叉中和作用,来自患者和 BALB/c 小鼠对登革热和基孔肯雅热病毒的反应。
Viruses. 2024 Jul 8;16(7):1098. doi: 10.3390/v16071098.

本文引用的文献

1
A pathogenic role for CD4+ T cells during Chikungunya virus infection in mice.在小鼠感染基孔肯雅病毒过程中 CD4+T 细胞的致病作用。
J Immunol. 2013 Jan 1;190(1):259-69. doi: 10.4049/jimmunol.1202177. Epub 2012 Dec 3.
2
Viperin restricts chikungunya virus replication and pathology.Viperin 限制基孔肯雅病毒的复制和病理。
J Clin Invest. 2012 Dec;122(12):4447-60. doi: 10.1172/JCI63120. Epub 2012 Nov 19.
3
Longitudinal analysis of the human antibody response to Chikungunya virus infection: implications for serodiagnosis and vaccine development.对人类感染基孔肯雅病毒的抗体反应的纵向分析:对血清诊断和疫苗开发的影响。
J Virol. 2012 Dec;86(23):13005-15. doi: 10.1128/JVI.01780-12. Epub 2012 Sep 26.
4
Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock.干扰素反应因子 3 和 7 可预防基孔肯雅出血热和休克。
J Virol. 2012 Sep;86(18):9888-98. doi: 10.1128/JVI.00956-12. Epub 2012 Jul 3.
5
The evolving epidemiology of HIV/AIDS.HIV/AIDS 流行病学的演变。
AIDS. 2012 Jun 19;26(10):1205-13. doi: 10.1097/QAD.0b013e328354622a.
6
Mouse models for Chikungunya virus: deciphering immune mechanisms responsible for disease and pathology.基孔肯雅热病毒的小鼠模型:解析疾病和病理的免疫机制。
Immunol Res. 2012 Sep;53(1-3):136-47. doi: 10.1007/s12026-012-8266-x.
7
Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection.中和免疫球蛋白 G3 抗体的早期出现与基孔肯雅病毒的清除和长期临床保护有关。
J Infect Dis. 2012 Apr 1;205(7):1147-54. doi: 10.1093/infdis/jis033. Epub 2012 Mar 1.
8
Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein.感染患者对基孔肯雅病毒的早期中和 IgG 应答靶向 E2 糖蛋白上的一个显性线性表位。
EMBO Mol Med. 2012 Apr;4(4):330-43. doi: 10.1002/emmm.201200213. Epub 2012 Mar 5.
9
The evolving Indian AIDS epidemic: hope & challenges of the fourth decade.不断演变的印度艾滋病疫情:第四个十年的希望与挑战
Indian J Med Res. 2011 Dec;134(6):739-41. doi: 10.4103/0971-5916.92618.
10
Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate.干扰素-α/β缺乏极大地加重了感染野生型基孔肯雅病毒的小鼠的关节炎疾病,但对细胞培养适应的减毒活疫苗候选株 181/25 则没有影响。
Virology. 2012 Apr 10;425(2):103-12. doi: 10.1016/j.virol.2011.12.020. Epub 2012 Feb 1.